IEFM
NRIX icon

IQ EQ Fund Management’s Nurix Therapeutics NRIX Stock Holding History

IQ EQ Fund Management’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.18M Buy
89,885
+8,125
+10% +$138K 0.14% 140
2026
Q1 		$1.27M Buy
81,760
+16,215
+25% +$269K 0.1% 183
2025
Q4 		$1.24M Buy
65,545
+22,786
+53% +$327K 0.09% 188
2025
Q3 		$395K Buy
42,759
+16,353
+62% +$170K 0.03% 271
2025
Q2 		$301K Buy
26,406
+12,157
+85% +$131K 0.03% 274
2025
Q1 		$169K Buy
+14,249
New +$238K 0.02% 287

Other funds holding NRIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

IQ EQ Fund Management's NRIX Position: Q2 2026 in Review

IQ EQ Fund Management increased its Nurix Therapeutics (NRIX) stake by 9.9% in Q2 2026, buying an estimated $138K and bringing the position to 89,885 shares worth $2.18M. The position accounts for 0.14% of the portfolio, ranked #140.

IQ EQ Fund Management first reported a position in NRIX in Q1 2025 and has held it in 6 quarters since. 211 funds tracked by Wall St. Rank hold NRIX as of Q2 2026.

  • IQ EQ Fund Management held 89,885 shares of Nurix Therapeutics worth $2.18M as of Q2 2026.
  • IQ EQ Fund Management bought 8,125 Nurix Therapeutics shares in Q2 2026, an estimated $138K.
  • Nurix Therapeutics made up 0.14% of IQ EQ Fund Management's portfolio in Q2 2026, its #140 holding.
  • IQ EQ Fund Management first reported a position in Nurix Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 211 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q2 2026.

Based on IQ EQ Fund Management's 13F filing for Q2 2026, filed 31 Jul 2026.